Clinuvel Pharmaceuticals (CUV)

Download button icon Download

Clinuvel Pharmaceuticals (CUV): Signals

No data currently available.

data-ad-format="auto">

Explore Compare Share

TECHNICAL ANALYSIS SUMMARY

No continuation candles currently present.


PROFILE: Clinuvel Pharmaceuticals (CUV.AX)


Stock Exchange: ASX
Company: Clinuvel Pharmaceuticals
Ticker Codes: | CUV.AX | ASX:CUV |

About Clinuvel Pharmaceuticals (ASX:CUV):

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of a range of severe skin disorders. Its lead drug compound is SCENESSE, a medicinal photoprotective and repigmentation drug that has completed Phase II and III trials in the United States and Europe, which is used for the prevention of phototoxicity in adults with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue that acts as a potent skin protectant; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. It has operations in Europe, the United States, and Singapore. The company is headquartered in Melbourne, Australia.

Top 10:

Continuation Candlestick

Download button icon Download
Company Close Change (%) Volume Value Signal
SYR Syrah Resources 1.81 8.1 2,657,646 1 BULLISH
AHY Asaleo Care 0.96 7.9 1,041,352 1 BULLISH
TNG Tennant Creek Gold 0.1 6.4 1,371,512 1 BULLISH
MOY Millennium Minerals 0.19 5.7 282,159 1 BULLISH
RND Rand Mining 2 5.3 32,715 1 BULLISH
SVW Seven Holdings 14.71 4.8 723,235 1 BULLISH
NEA Nearmap 1.58 4.3 958,935 1 BULLISH
PMC Platinum Capital 1.79 4.1 152,348 1 BULLISH
WHC Whitehaven Coal 4.63 4 8,137,675 1 BULLISH
CAJ Capitol Health 0.29 3.6 381,190 1 BULLISH
back to top